{"id":3542,"date":"2021-01-21T11:11:24","date_gmt":"2021-01-21T11:11:24","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=3542"},"modified":"2021-01-21T11:11:25","modified_gmt":"2021-01-21T11:11:25","slug":"cuba-will-produce-100-million-doses-of-its-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cuba-will-produce-100-million-doses-of-its-covid-19-vaccine\/","title":{"rendered":"Cuba will produce 100 million doses of Its Covid-19 vaccine"},"content":{"rendered":"\n

This year, Cuba will produce 100 million doses of its new Soberana\u00a002 coronavirus vaccine\u00a0to\u00a0meet its\u00a0internal demand and those of other countries, a leading\u00a0Cuban scientist reported on Wednesday.<\/strong><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

We are reorganizing our production capacities because we really have a lot of demand for the vaccine and we have to prepare ourselves,” Vicente V\u00e9rez, director of the Finlay Institute, told a group of journalists at a conference in which he gave a tour of the laboratory where the vaccine against COVID-19 is manufactured.The Finlay Institute has created both Soberana 02 and Soberana 01, the latter in a less advanced research phase. Other biotechnology centers on the island are working on two more vaccine candidates, Abdala and Mambisa.The 100 million doses planned would be only of Soberana 02. There are already countries interested in acquiring it, such as Vietnam, Iran, and Venezuela, among others, with which the island has collaboration agreements, including Pakistan and India, V\u00e9rez said.This week began the second part of a Phase II trial of this product with 900 patients — who joined about a hundred from the first stage — at a polyclinic in the capital; The Associated Press reported the day before.The volunteers — one group of whom received a placebo as part of the study, although they will be immunized with the actual vaccine once it is over — said they reported no discomfort. Even some neighbors at the polyclinic came forward to volunteer as part of the trial.After being injected, people–ranging in age from 19 to 80 years–waited at the same polyclinic before returning home and were followed up at 24, 48, and 72 hours.V\u00e9rez stressed that the antigen is safe after pointing out that it does not contain the live virus. Still, parts of it, so\u2014according to the expert\u2014its placement generates immunity but does not cause significant reactions and therefore does not need extra refrigeration, like other candidates in the world.Meanwhile, Finlay’s researchers are working with countries such as Italy and Canada to verify the impact of these vaccines -especially Soberana 01- on people who have already had COVID-19 and are convalescent but at risk of reinfection. Effectiveness is also being assessed for the impact of new mutations such as the one described in Great Britain, Japan, or California.Over the next few weeks, vaccination will be extended to 150,000 people on the island, confirmed V\u00e9rez, on the way to mass immunization, and a test will be carried out in February to protect children with Soberana 02, he said.After several months of keeping the pandemic under control, Cuba suffered a resurgence at the beginning of this year, after the opening of its airports and despite having a preventive health protocol. From March to date, 19,122 infections and 180 deaths have accumulated on the island.The scientist did not offer details of the price that the vaccine will have for its sale to other countries. In Cuba, its administration will be free and voluntary.Despite being a small country, Cuba has a developed scientific pole that produces almost all the vaccines it needs and state-of-the-art medicines.”Cuba’s strategy of commercializing the vaccine has a combination of humanity and impact on health and the need of our system to sustain (financially) the production of vaccine and medicines for the country,” expressed V\u00e9rez.”We are not a multinational where the (financial) return is the number one reason,” he added. “We work the other way around; creating more health and return is a consequence; it will never be the priority.”<\/p>\n\n\n\n

Source: TeleSur<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

This year, Cuba will produce 100 million doses of its new Soberana\u00a002 coronavirus vaccine\u00a0to\u00a0meet its\u00a0internal demand and those of other countries, a leading\u00a0Cuban scientist reported […]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":3543,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[43],"tags":[],"class_list":["post-3542","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":5590,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-bet-on-home-grown-covid-vaccines-is-paying-off\/","url_meta":{"origin":3542,"position":0},"title":"Cuba\u2019s bet on home-grown COVID vaccines is paying off","author":"Editorial Team","date":"November 30, 2021","format":false,"excerpt":"A health-care worker vaccinates a woman with the Abdala jab in August.Credit: Yamil Lage\/AFP via Getty Preprint data show that a three-dose combo of Soberana jabs has 92.4% efficacy in clinical trials. When the COVID-19 pandemic began, Cuba decided not to wait on the rest of the world to develop\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":4747,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-soberana-02-covid-19-vaccine-to-reach-95-efficiency\/","url_meta":{"origin":3542,"position":1},"title":"Cuba’s Soberana 02 COVID-19 Vaccine To Reach 95% Efficiency","author":"Editorial Team","date":"June 27, 2021","format":false,"excerpt":"The\u00a0clinical trial's\u00a0preliminary results show a significant increase in the immune responses of patients between the second and third doses. On Thursday, Cuba\u2019s Finlay Vaccine Institute announced that its Soberana 02 COVID-19 vaccine is most likely to reach\u00a0up to\u00a095 percent efficiency in third phase of clinical trials. FVI scientist Maria Toledo\u2026","rel":"","context":"In "Featured"","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":4712,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-abdala-vaccine-proved-92-28-effective-in-last-stage-clinical-trials\/","url_meta":{"origin":3542,"position":2},"title":"Cuba’s Abdala vaccine proved 92.28% effective in last-stage clinical trials.","author":"Editorial Team","date":"June 22, 2021","format":false,"excerpt":"Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials. The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. \"Hit by the pandemic, our scientists\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":4100,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-one-step-away-from-achieving-the-first-latin-american-vaccine-against-covid-19\/","url_meta":{"origin":3542,"position":3},"title":"Cuba, one step away from achieving the first Latin American vaccine against Covid-19","author":"Editorial Team","date":"April 22, 2021","format":false,"excerpt":"By\u00a0Mauricio Vicent They are called Soberana 02 and Abdala, and they are the two Cuban vaccine candidates against covid-19 that have gone the furthest in their development. Both are in phase 3 \u2014 the last before approval \u2014 of clinical trials. If everything goes as Cuban scientists hope, before the\u2026","rel":"","context":"In "Cuba"","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vaccine.jpeg?fit=750%2C430&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3049,"url":"https:\/\/www.cubasupport.ie\/latest\/cuban-vaccine-soberana-02-to-start-phase-clinical-trials\/","url_meta":{"origin":3542,"position":4},"title":"Cuban Vaccine Soberana 02 To Start Phase Clinical Trials","author":"Editorial Team","date":"October 30, 2020","format":false,"excerpt":"Soberana 02 is the second Cuban COVID-19 vaccine candidate to begin clinical trials after being approved by Cuba's\u00a0medical regulatory authorities. The Cuban vaccine candidate against COVID-19, Soberana 02, will start Phase I clinical trials after receiving the approval of the Center for State Control of Drugs, Equipment, and Medical Devices\u2026","rel":"","context":"In "Featured"","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":5673,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-now-exporting-covid-vaccines\/","url_meta":{"origin":3542,"position":5},"title":"Cuba now exporting Covid vaccines","author":"Editorial Team","date":"December 18, 2021","format":false,"excerpt":"After immunising its own population, Cuba\u2019s own developed vaccines are to be marketed internationally, says ANDREAS KNOBLOCH Cuban volunteer doctors visit a slum in Caracas, Venezuela, April 2020 AS RECENTLY as August and September, Cuba had to cope with the most severe Covid outbreak to date, which pushed the health\u2026","rel":"","context":"In "Cuba"","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/10-cuban-volunteers-in-venezuela-AP_20108732454437.jpeg?fit=1180%2C585&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/10-cuban-volunteers-in-venezuela-AP_20108732454437.jpeg?fit=1180%2C585&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/10-cuban-volunteers-in-venezuela-AP_20108732454437.jpeg?fit=1180%2C585&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/10-cuban-volunteers-in-venezuela-AP_20108732454437.jpeg?fit=1180%2C585&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/10-cuban-volunteers-in-venezuela-AP_20108732454437.jpeg?fit=1180%2C585&ssl=1&resize=1050%2C600 3x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-V8","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuba-vaccine.jpg?fit=713%2C453&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=3542"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3542\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/3543"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=3542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=3542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=3542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}